Trademark Overview
On Friday, March 6, 2026, a trademark application was filed for YORQINTA with the United States Patent and Trademark Office. The USPTO has given the YORQINTA trademark a serial number of 99686766. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 6, 2026. This trademark is owned by Pfizer Inc.. The YORQINTA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, pulmonary, respiratory, and viral diseases and disorders;; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, asthma, cancer, cachexia, chronic obstructive pulmonary disease (COPD), eczema, hypertension, migraine, pain, stroke, obesity and diabetes;; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
